Researchers trial self-administration of flu vaccine; Sinovac publishes PhIII data in NEJM;

> A study has found self-administration of the flu vaccine using microneedle patches may be feasible. Research

> Sinovac has published data from a Phase III trial of its hand, foot and mouth disease vaccine in the NEJM. Release

> Academics are working with two pharmaceutical companies to translate their dengue virus breakthrough into a vaccine. Item

> The WHO is to help vaccinate 140,000 people in South Sudan against cholera. News

> The CDC has made no changes to its flu vaccine recommendations for 2014-2015. Article

> TheStreet's Adam Feuerstein has assessed the likelihood of NewLink Genetic's ($NLNK) pancreatic cancer vaccine winning approval. Feature

> Bavarian Nordic has won a U.S. Department of Defense contract to develop a vaccine against two biological threats. Item

> An investigation into an adverse event following use of Novartis' ($NVS) Bexsero at Princeton University suggests the vaccine was unlikely to have been the cause. Piece

> Vietnam is importing almost 80,000 doses of the chickenpox vaccine to tackle an epidemic. News

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.